Testicular cancer differential diagnosis: Difference between revisions

	Testicular cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Testicular cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Testicular cancer differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Testicular cancer differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Testicular cancer differential diagnosis
CDC on Testicular cancer differential diagnosis
Testicular cancer differential diagnosis in the news
Blogs on Testicular cancer differential diagnosis
Directions to Hospitals Treating Testicular cancer
Risk calculators and risk factors for Testicular cancer differential diagnosis

← Older edit Newer edit →

VisualWikitext

Revision as of 15:01, 23 January 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.

Differentiating Testicular cancer from other Diseases

Testicular cancer must be differentiated from:

							Pain	Mass	Physical examination	Lab Findings	Imaging
Diseases		Benign/ Malignant	Unilateral/Bilateral	History	Metastasis	Genetics	Clinical manifestations			Para-clinical findings
							Pain	Mass	Physical examination	Para-clinical findings
Germ Cell	Seminoma
	Embryonal carcinoma
	Yolk sac tumor
	Teratoma
	Choriocarcinoma
Diseases		Benign/ Malignant	Unilateral/Bilateral	History	Metastasis	Genetics	Pain	Mass	Physical exam	Lab Findings	Imaging
Non germ cell	Leydig cell tumor
	Sertoli cell tumor
	Testicular lymphoma
Carcinoma in situ of the testicle

References

Template:WikiDoc Sources

@@ Line 27: / Line 27: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" rowspan="5" |Germ Cell
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Seminoma
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 33: / Line 32: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 39: / Line 39: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" | Embryonal carcinoma
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 45: / Line 44: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 51: / Line 51: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Yolk sac tumor
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 57: / Line 56: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 63: / Line 63: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Teratoma
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 69: / Line 68: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 75: / Line 75: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Choriocarcinoma
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 81: / Line 80: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 87: / Line 87: @@
 |-
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" colspan="2" |Diseases
-!
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign/ Malignant
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Unilateral/Bilateral
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
@@ Line 100: / Line 100: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" rowspan="3" |Non germ cell
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Leydig cell tumor
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 106: / Line 105: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 112: / Line 112: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Sertoli cell tumor
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 118: / Line 117: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 124: / Line 124: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Testicular lymphoma
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 130: / Line 129: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 136: / Line 136: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" colspan="2" |Carcinoma in situ of the testicle
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 142: / Line 141: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
+| style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |

Testicular cancer differential diagnosis: Difference between revisions

Revision as of 15:01, 23 January 2019

Overview

Differentiating Testicular cancer from other Diseases

References

Navigation menu

Search